CRG Partners III - Parallel Fund (A) L.P.

10% OwnerT2 Biosystems, Inc. (TTOO) · full profile →Form 4 · filed Feb 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2024Conversion(C)336K336K
Feb 14, 2024Conversion(C)488K488K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Conversion(C)49K$011K
Feb 14, 2024Conversion(C)34K$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-004167) within minutes of acceptance. Every field above traces to the original document. Verify it directly: